Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher - PepGen ( NASDAQ:PEPG ) , Capricor Therapeutics ( NASDAQ:CAPR )
Capricor Therapeutics Inc. CAPR is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like Duchenne muscular dystrophy ( DMD ) . Capricor's stock surged more than 100% after announcing it will pursue full FDA approval for its primary drug deramiocel ( ...
| Ticker |
Sentiment |
Impact |
|
PEPG
|
Neutral
|
8 %
|
|
SRPT
|
Somewhat Bullish
|
12 %
|
|
CAPR
|
Neutral
|
17 %
|
|
NPNKF
|
Neutral
|
4 %
|
